Therapeutic Drug Monitoring of Adalimumab in Psoriasis Patients
NCT02147600
·
clinicaltrials.gov ↗
COMPLETED
Status
82
Enrollment
OTHER
Sponsor class
Conditions
Psoriasis
Sponsor
University Hospital, Ghent